elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
CD33
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
CD33
RIS
0.001
(Research Intensity Score)
Papers
114
Top papers
Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation
2025 · 19 citations
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
2023 · 36 citations
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy
2025 · 12 citations
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
2022 · 64 citations
Addressing Clinical Challenges of Platinum Anticancer Drugs through Rational Chemical Design
2026
Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy
2024 · 9 citations
[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy
2026
Abstract 5827: Actimab-A, a CD33-targeted actinium-225 radioconjugate, drives mutation-agnostic anti-leukemic activity and synergizes with standard therapies in AML through transcriptional reprogramming
2026
Monoclonal Antibodies Against Myeloid Leukemia Cells: Current Knowledge and Future Directions
2025 · 3 citations
Newest papers
Addressing Clinical Challenges of Platinum Anticancer Drugs through Rational Chemical Design
2026
[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy
2026
Abstract 5827: Actimab-A, a CD33-targeted actinium-225 radioconjugate, drives mutation-agnostic anti-leukemic activity and synergizes with standard therapies in AML through transcriptional reprogramming
2026
Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation
2025 · 19 citations
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy
2025 · 12 citations
Monoclonal Antibodies Against Myeloid Leukemia Cells: Current Knowledge and Future Directions
2025 · 3 citations
CD7-targeted universal CAR T-cell therapy in relapsed or refractory (R/R) acute myeloid leukemia (AML): Clinical results from CTD401/402 studies
2025
Comparison of radiobiological effects induced by radiolabeled antibodies in human cancer cells and fungal cells
2025 · 2 citations
Abstract 594: Lintuzumab-Ac225 has potent mutation agnostic antileukemic activity in preclinical models of AML
2025 · 1 citations
Browse all papers →
CD33's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
CD33's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link